Rein Therapeutics Inc. (RNTX) vs TherapeuticsMD, Inc. (TXMD)
A side-by-side comparison of Rein Therapeutics Inc. and TherapeuticsMD, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
RNTX
Rein Therapeutics Inc.
$0.82HealthcareDelayed quote: Oct 6, 2026, 2:25 PM EDT
TXMD
TherapeuticsMD, Inc.
$2.06HealthcareDelayed quote: Oct 6, 2026, 2:23 PM EDT
Total return — RNTX vs TXMD
growth of $100 · dividends reinvested · last 2yRNTX -61.1% (-37.6%/yr)TXMD +60.8% (+26.8%/yr)TXMD compounded faster over this window
RNTX TXMD
RNTX vs TXMD: by the numbers
- •TXMD is the larger company ($24M vs $23M market cap).
- •Both run net losses; RNTX's is the smaller (0.00% vs -6.64% net margin).
Metrics side by side
Valuation
| Metric | RNTX | TXMD |
|---|---|---|
| Forward P/E | N/A | 12.12 |
| P/S ratio | N/A | 7.29 |
| P/B ratio | 2.24 | 0.88 |
| FCF yield | N/A | 13.09% |
Profitability
| Metric | RNTX | TXMD |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -139.44% |
| Net margin | 0.00% | -6.64% |
| ROE | -487.90% | -0.80% |
| ROIC | -36.89% | -11.84% |
Growth (annualized)
| Metric | RNTX | TXMD |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -47.86% |
| Total return CAGR (5Y) | N/A | -44.16% |
Go deeper
Dig into the metrics
Rein Therapeutics ROETherapeuticsMD ROERein Therapeutics operating marginTherapeuticsMD operating marginRein Therapeutics revenue growthTherapeuticsMD revenue growthRein Therapeutics free cash flowTherapeuticsMD free cash flow
Rein Therapeutics & TherapeuticsMD appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.